These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Association between nonsteroidal anti-inflammatory drugs and prostate cancer occurrence. Dasgupta K, Di Cesar D, Ghosn J, Rajan R, Mahmud S, Rahme E. Cancer J; 2006; 12(2):130-5. PubMed ID: 16630404 [Abstract] [Full Text] [Related]
4. Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population. Mahmud SM, Tanguay S, Bégin LR, Franco EL, Aprikian AG. Eur J Cancer Prev; 2006 Apr; 15(2):158-64. PubMed ID: 16523013 [Abstract] [Full Text] [Related]
5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS. Oncologist; 1996 Apr; 1(5):326-330. PubMed ID: 10388011 [Abstract] [Full Text] [Related]
11. Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study. Hippisley-Cox J, Vinogradova Y, Coupland C, Parker C. Arch Gen Psychiatry; 2007 Dec; 64(12):1368-76. PubMed ID: 18056544 [Abstract] [Full Text] [Related]
14. Medical history, body size, and cigarette smoking in relation to fatal prostate cancer. Weinmann S, Shapiro JA, Rybicki BA, Enger SM, Van Den Eeden SK, Richert-Boe KE, Weiss NS. Cancer Causes Control; 2010 Jan; 21(1):117-25. PubMed ID: 19816779 [Abstract] [Full Text] [Related]